尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Ye Weiguo. Director active across 1 company, notably GYRE THERAPEUTICS, INC.. Aggregated, 10 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €39k. History available since 24 March 2025. The latest transaction was disclosed on 26 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Ye Weiguo is a declarant linked to GYRE THERAPEUTICS, INC., where the listed role is Chief Operating Officer. He has 10 filings in total, and across the 10 sampled filings from 2025-04-25 to 2026-06-11, the sell amount is EUR 39280, with Levée d'options as the modal transaction nature.